CEVR Participation at ISPOR 2026 - Center for the Evaluation of Value and Risk in Health

CEVR faculty and researchers will present their research during several discussions and poster sessions at ISPOR 2026 in Philadelphia, PA

Monday, May 18

Issues Panel

10:30 – 11:30 am: Value-Based Pricing for CMS Drug Price Negotiation: Mission Impossible?
- Moderator: Peter Neumann, ScD, Tufts Medical Center (CEVR)
- Speakers: Feng Xie, PhD, McMaster University; Sean D Sullivan, PhD, University of Washington; Joshua Cohen, PhD, Tufts Medical Center (CEVR)
10:30 – 11:30 am: Evolving Approaches to Measuring Benefits in Economic Evaluation: Do the Health Economics Methods Advisory (HEMA) Recommendations Go Far Enough for Global HTA Practice?
- Moderator: William V Padula, PhD, University of Southern California
- Speakers: Darius Lakdawalla, PhD, University of Southern California; Dan Ollendorf, MPH, PhD, ICER and Tufts Medical Center (CEVR); Lotte Steuten, MSc, PhD, Office of Health Economics
1:45 – 2:45 pm: Whose Preferences Should Govern Health Technology Adoption? Debating the Foundations and the Future of Value Assessment
- Moderator: Clifford Goodman, MS, PhD, Clifford Goodman LLC
- Speakers: Darius Lakdawalla, PhD, University of Southern California; Andrew Briggs, DPhil, London School of Hygiene & Tropical Medicine; Melanie D Whittington, MS, PhD, Leerink Center for Pharmacoeconomics and Tufts Medical Center (CEVR)

Research Podiums

10:30 – 11:30 am: Opening the Black Box: A Human-Governed Agentic AI Framework for Health Economic Modeling
- Authors: Haidong Feng, MPH, Merck; Augustine Annan, PhD, NouStarX; Hannah Paek, BA, Binghamton University; Meng Li, MS, PhD Tufts Medical Center (CEVR); Xiaoyan Wang, PhD, Tulane University
1:45 – 2:45 pm: Economic Evaluations and Value Considerations in ACIP Routine Vaccine Recommendations: A Comprehensive Review
- Authors: Tyler D. Wagner, PharmD, National Pharmaceutical Council; Peter Neumann, ScD, Tufts Medical Center (CEVR), Jon D. Campbell, PhD, National Pharmaceutical Council; David Strutton, MPH, PhD, Independent Consultant and CEVR Fellow

Forums

3:15 – 4:15 pm: HEOR at U.S. Federal Agencies: State of the Science
- Speakers: Peter Neumann, ScD, Tufts Medical Center (CEVR); Laura Pizzi, MPH, PharmD, ISPOR; Donna Rivera, MSc, PharmD, Canal Row Advisors; Rachael Fleurence, MSc, PhD, Apodeixis Strategies, LLC
3:15 – 4:15 pm: Good Practices Reports in Action: Advancing Evidence for Policy, Access, and Value
- Moderator: Elizabeth Molsen-David, RN, ISPOR
- Speakers: Onyeka Illoh, MPH, PhD, U.S. FDA; Jens Grueger, PhD, Boston Consulting Group; Dan Ollendorf, MPH, PhD, ICER and Tufts Medical Center (CEVR); Louis Matza, PhD, Thermo Fisher Scientific

Workshops

4:45 – 5:45 pm: The Metrics Behind the Money: Case Studies and Insights From Bridging Health Economics and Investment
- Moderator: Melanie D Whittington, MS, PhD, Leerink Center for Pharmacoeconomics and Tufts Medical Center (CEVR)
- Speakers: Meng Li, MS, PhD, Tufts Medical Center (CEVR); Richard Xie, PhD, RA Capital Management; Sorochi Van Sickle, PhD, Patient Square Capital

Educational Symposia

12:15 – 1:15 pm: Measuring What Matters: Broader Value Elements in HTA and Their Impact on Access
- Moderator: Graham Cookson, MA, MSc, PhD, Office of Health Economics, London
- Speakers: Oriol de Sola-Morales, MSc, PhD, MD, Fundacio HiTT; Lotte Steuten, MSc, PhD, Office of Health Economics; Jon Tosh, BA, MSc, PhD, ViiV Healthcare; Jon D Campbell, MS, PhD, National Pharmaceutical Council and Tufts Medical Center (CEVR)
3:15 – 4:15 pm: MFN Meets IRP: How US Pricing Reform Reshapes Global Market Interdependencies
- Moderator: Casper Paardekooper, MSc, Cencora
- Speakers: David Ringger, PhD, Cencora; Jon D Campbell, MS, PhD, National Pharmaceutical Council and Tufts Medical Center (CEVR); Scott Greig, MS, Sanofi; Indranil Bagchi, MS, PhD, GSK US

Posters

Tuesday, May 19

Issues Panel

10:30 – 11:30 am: Are Drug Prices Rising Too Fast? Rethinking Inflation Benchmarks Through the Lens of Value, Access, and Innovation
- Moderator: William V Padula, PhD, University of Southern California
- Speakers: Jon D Campbell, MS, PhD, National Pharmaceutical Council and Tufts Medical Center (CEVR); Laura Pizzi, MPH, PharmD, ISPOR; Andrew York, JD, PharmD, Maryland Prescription Drug Affordability Board
1:45 – 2:45 pm: Coordinating the Quagmire: Real-World Evidence in Value Assessment in Later Stages of the Product Life Cycle
- Moderator: Ambarish J. Ambegaonkar, PhD, APPERTURE LLC
- Speakers: Shanthy Krishnarajah, Johnson and Johnson; Laura Pizzi, MPH, PharmD ISPOR; Dan Ollendorf, MPH, PhD, ICER and Tufts Medical Center (CEVR)

Forums

3:15 – 4:15 pm: A New Gold Standard for Valuing Health-Related Quality of Life? The Impact of the New UK EQ-5D-5L Utilities for HEOR and Decision Makers. A Value in Health Forum
- Moderator: Dan Ollendorf, MPH, PhD, ICER and Tufts Medical Center (CEVR)
- Speakers: Yemi Oluboyede, MSc, PhD; Allan Wailoo, BSc, MA, MSc, PhD, ScHARR; Feng Xie, PhD, McMaster University

Workshops

1:45 - 2:45 pm: Incorporating Patient, Family, and Public Perspectives to Advance Novel and Societal Elements of Value in Value Assessment
- Moderator: Richard Xie, PhD, RA Capital Management, Newton, MA, United States
- Speakers: Meng Li, MS, PhD, Tufts Medical Center (CEVR); Julia F. Slejko, PhD, University of Maryland Baltimore; Jingyan Yang, DrPH, Pfizer Inc

Posters

10:30 am – 1:30 pm:
- HPR70: Variation in Casgevy and Lyfgenia Coverage Criteria Across State Medicaid Plans
  - Claire Brennan, BA
4:00 – 7:00 pm
- HSD99: Trends in Specialty Drug Coverage Policy Complexity Among US Commercial Health Plans
  - Julia Rucker, MSW, MPH
- HPR127: A Survey of HEOR Leaders in Pharma on the Changing US Policy Landscape
  - Lu Shi, PhD
- EE420: Use of Novel Elements of Value in Cost-Effectiveness Analyses: Insights from the CEA Registry (2016–2024)
  - Xiaoyan Wang, MPH

Wednesday, May 20

Issues Panel

10:00 – 11:00 am: From Debate to Dialogue: Building Consensus on Prior Authorization Reform
- Moderator: Kimberly Westrich, MA, National Pharmaceutical Council
- Speakers: John Watkins, MPH, PharmD, University of Washington; James Chambers, MSc, PhD, Tufts Medical Center (CEVR); Anna Hyde, MA, Arthritis Foundation

Workshops

10:00 – 11:00 am: Strategic Integration of Generative AI in Health Economic Modeling: Emerging Methods, Implementation, Evaluation, and HTA Implications
- Moderator: Meng Li, MS, PhD, Tufts Medical Center (CEVR)
- Speakers: Xiaoyan Wang, PhD, Tulane University; Haidong Feng, MPH, MS, Merck; Abigail Wright, Institute for Clinical and Economic Review

Posters